2026 Agenda





Medtech MVP
Investing in Medtech’s Future through Insight and Innovation Sharing
6/1/2026 - June 2, 2026 ALL TIMES CDT
Now in its 25th year, the Medtech MVP Venture & Partnering Conference continues to bring together top innovators, investors, and executives shaping the future of medical technology. Known for its candid panel discussions, fireside chats, town-hall forums, and high-value networking, Medtech MVP offers an inside look at the forces driving growth across the medtech ecosystem—from capital strategy and clinical innovation to regulatory and market dynamics. This year’s program will explore the road ahead for smaller companies navigating a shifting economy and new administration, and spotlight emerging technologies through a dynamic pitch contest and company showcase. Additional sessions will dive into the evolving M&A vs. IPO landscape, advances in neurostimulation, the convergence of software and hardware, AI and GenAI applications in medtech, effective clinical-trial design, regulatory updates, and compelling patient stories that remind us why innovation matters. Join industry leaders and visionaries as we celebrate 25 years of connection, collaboration, and progress—and set the stage for the next era of medtech innovation.
Preliminary Agenda

Keynote Interview

Photo of Geoff Martha, Chairman & CEO, Medtronic , Chairman & Chief Executive Officer , Medtronic
Geoff Martha, Chairman & CEO, Medtronic , Chairman & Chief Executive Officer , Medtronic

Panel Moderator:

PANEL DISCUSSION:
How Health Systems are Adopting Robotics across Care Settings

Virginia L. Giddings, PhD, Vice President, Exploration, Edwards Lifesciences , Vice President, Exploration , Exploration , Edwards Lifesciences

Health systems are evaluating robotics not only for surgical precision, but also for their potential to address workforce shortages, improve efficiency, and enhance care delivery across multiple settings. From the operating room to inpatient units, rehabilitation, logistics, and remote care, this session examines where robotics are delivering real value and what it takes to scale adoption across the healthcare enterprise. 


  • Where are health systems seeing the strongest clinical and operational impact from robotics today?
  • How are robotics investment decisions being evaluated beyond the operating room?
  • Which workforce challenges—staffing shortages, burnout, training—are robotics helping to address?
  • How are robotics integrated into existing clinical workflows without disrupting care delivery?
  • What economic, reimbursement, or ROI factors most influence adoption decisions?
  • How will robotics adoption evolve as AI and automation capabilities advance?​

Panel Moderator:

PANEL DISCUSSION:
Investing in Medtech Now: Where Capital is Moving - and Why

Maria Berkman, MD, MBA, Partner, Vensana Capital , Partner , Vensana Capital

Panelists:

Jan Garfinkle, Managing Partner, Arboretum Ventures , Managing Partner , Arboretum Ventures

David Lewis, Managing Partner, Gilmartin Capital , Managing Partner , Gilmartin Capital LLC

Darshana Zaveri, Founder & Managing Partner, Catalyst Health Ventures , Managing Partner , Catalyst Health Ventures

Panel Moderator:

PANEL DISCUSSION:
From Start-up to Scale-up: What it Took to Reach Mid-Stage—And What Comes Next

Lori Chmura, CEO, Leadership, Nyra Medical , CEO , Leadership , Nyra Medical

Reaching mid-stage is a defining milestone for MedTech companies—but scaling beyond it presents new operational, regulatory, and capital challenges. This CEO-led discussion explores the decisions, tradeoffs, and inflection points that shaped their growth, including how geography, talent hubs, and ecosystem support influenced their trajectory. 


  • What specific inflection point signaled you were no longer an “early-stage company”—and how did that change how you operated?
  • Which decisions you made at Series A or B mattered most in getting to mid-stage, and which ones would you revisit?
  • How did your regulatory and reimbursement strategy need to evolve once early traction turned into commercial demand?
  • What role did geography play in access to talent, capital, and customers—and how has that changed as you’ve scaled?
  • Looking ahead, what will most determine your next phase of growth: capital, regulatory pathways, market access, or organizational maturity?
  • What advice would these CEOs give founders planning their next phase of growth?​

CONFERENCE CONTENT

Ben Lakin, PhD
Chief Executive Officer
(+1) 781-972-5454
blakin@cambridgeinnovationinstitute.com

Jason Green
Senior Conference Director
jgreen@cambridgeinnovationinstitute.com

PARTNERING & SPONSORSHIP

Brian Caine
Manager, Strategic Partnerships
Venture, Innovation & Partnering (VIP) Event Series
(+1) 908-809-0946
bcaine@cambridgeinnovationinstitute.com